risk sharing

News

High Risk of Preventable and Mitigable Adverse Events in Cancer Care

08/22/2017

JCP Editors

Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...

...

08/22/2017

Journal of Clinical Pathways

Research in Review

CML Treatment Decisions Should Factor in Cardiovascular Disease Risk

07/27/2017

JCP Editors

Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...

...

07/27/2017

Journal of Clinical Pathways

Research in Review

Increased Risk of Secondary Cancer for Survivors of Hodgkin Lymphoma

05/19/2017

JCP Editors

Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...

...

05/19/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma

05/19/2017

JCP Editors

A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...

A...

05/19/2017

Journal of Clinical Pathways

Research in Review

Mutations in CLL Cells May Be Used as Biomarker for Future Relapse

05/09/2017

JCP Editors

Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

Shorter Course of Radiation Therapy After Mastectomy Deemed Safe and Effective

05/08/2017

JCP Editors

A radiation schedule half the standard course is as safe and effective for patients with breast cancer following a mastectomy, according to a study published in the Journal of Clinical Oncology (published...

A...

05/08/2017

Journal of Clinical Pathways

Research in Review

Flu Vaccine May Cause Adverse Events for Lung Cancer Patients on Immunotherapy

05/03/2017

JCP Editors

Patients with lung cancer who are treated with immunotherapy may be at increased risk of severe adverse events after receiving the seasonal influenza vaccination, according to results of a study presented at the...

...

05/03/2017

Journal of Clinical Pathways

Research in Review

Ovarian Cancer Survival Influenced By Previous Comorbidities

05/02/2017

JCP Editors

Common comorbidities such as hypertension, heart disease, and diabetes may contribute to a woman’s prognosis after being diagnosed with ovarian cancer, according to a study published in Cancer Causes Control...

Common...

05/02/2017

Journal of Clinical Pathways

Research in Review

Removing Metastases Improves Survival for Patients With Kidney Cancer

04/28/2017

JCP Editors

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma

04/27/2017

JCP Editors

Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...

...

04/27/2017

Journal of Clinical Pathways